Bristol-Myers Squibb has been upgraded from a neutral to a strong rating according to new stock assessments, while Broadcom has been downgraded from a strong to a neutral rating. This evaluation is part of a comprehensive review of 142 blue-chip stocks conducted on October 1, 2023.
The stock grading includes several other notable changes: Arrow Electronics, CVS Health, and Steel Dynamics received upgrades to “very strong,” while companies such as Albemarle and Baker Hughes saw their ratings drop. Investors are encouraged to review these updates as they could impact personal investment strategies significantly.
The complete list of upgrades and downgrades is available, highlighting shifts in institutional buying pressure and each company’s fundamental health. For investors, it’s vital to keep abreast of such changes to optimize portfolio performance.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
